Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Mediators Inflamm

Retrieve available abstracts of 13 articles:
HTML format

Single Articles

    January 2022
  1. MISHRA J, Stubbs M, Kuang L, Vara N, et al
    Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering.
    Mediators Inflamm. 2022;2022:9621668.
    PubMed     Abstract available

  2. RODRIGUES BL, Dotti I, Pascoal LB, Morari J, et al
    Endoplasmic Reticulum Stress in Colonic Mucosa of Ulcerative Colitis Patients Is Mediated by PERK and IRE1 Pathway Activation.
    Mediators Inflamm. 2022;2022:6049500.
    PubMed     Abstract available

  3. HAN J, Li W, Shi G, Huang Y, et al
    Atractylenolide III Improves Mitochondrial Function and Protects Against Ulcerative Colitis by Activating AMPK/SIRT1/PGC-1alpha.
    Mediators Inflamm. 2022;2022:9129984.
    PubMed     Abstract available

  4. CHENG B, Rong AM, Li W, Bi X, et al
    DNMT3a-Mediated Enterocyte Barrier Dysfunction Contributes to Ulcerative Colitis via Facilitating the Interaction of Enterocytes and B Cells.
    Mediators Inflamm. 2022;2022:4862763.
    PubMed     Abstract available

  5. LYU YL, Zhou HF, Yang J, Wang FX, et al
    Biological Activities Underlying the Therapeutic Effect of Quercetin on Inflammatory Bowel Disease.
    Mediators Inflamm. 2022;2022:5665778.
    PubMed     Abstract available

  6. LIU J, Shi L, Huang W, Zheng Z, et al
    Homoharringtonine Attenuates Dextran Sulfate Sodium-Induced Colitis by Inhibiting NF-kappaB Signaling.
    Mediators Inflamm. 2022;2022:3441357.
    PubMed     Abstract available

    January 2021
  7. YOSHIMURA T, Mitsuyama K, Sakemi R, Takedatsu H, et al
    Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
    Mediators Inflamm. 2021;2021:8825374.
    PubMed     Abstract available

  8. ARAFAT EA, Marzouk RE, Mostafa SA, Hamed WHE, et al
    Identification of the Molecular Basis of Nanocurcumin-Induced Telocyte Preservation within the Colon of Ulcerative Colitis Rat Model.
    Mediators Inflamm. 2021;2021:7534601.
    PubMed     Abstract available

  9. GIUDICI F, Cavalli T, Luceri C, Russo E, et al
    Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients.
    Mediators Inflamm. 2021;2021:8854916.
    PubMed     Abstract available

  10. TAO Z, Zhou X, Zhang Y, Pu W, et al
    Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-alpha-Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy.
    Mediators Inflamm. 2021;2021:1610251.
    PubMed     Abstract available

  11. CUI X, Jiao C, Wang D, Ye Z, et al
    Elevated Levels of IL-27 Are Associated with Disease Activity in Patients with Crohn's Disease.
    Mediators Inflamm. 2021;2021:5527627.
    PubMed     Abstract available

    January 2020
  12. XIN Z, Zhai Z, Long H, Zhang F, et al
    Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:6020247.
    PubMed     Abstract available

  13. LIN J, Li G, Xu C, Lu H, et al
    Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities.
    Mediators Inflamm. 2020;2020:8812020.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.